Td Asset Management Inc Vaxart, Inc. Transaction History

Td Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$5.64 - $23.33 $388,336 - $1.61 Million	-68,854 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.5 - $7.98 $76,489 - $174,394	21,854 Added 46.5%	68,854 $393,000
Q3 2020 Nov 10, 2020	BUY	$4.78 - $16.97 $224,660 - $797,590	47,000 New	47,000 $313,000

109

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $78.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.